ÂÜÀòÂÒÂ×

Erin Burkhart serves as Group Vice President and Chief Accounting Officer at BioMarin Pharmaceutical Inc. since May 2022. Previously, Erin held multiple leadership roles at Eli Lilly and Company from August 2014 to May 2022, including Associate Vice President for US Gross-to-Net Business Analysis, Accounting Operations and Reporting, and Senior Director of Corporate Audit Services. Prior experience includes a position as Director of Financial Reporting at Stonegate Mortgage Corporation, Finance Director of the Specialty Business Unit at WellPoint, and various roles at Guidant, Deloitte, and Arthur Andersen. Erin earned a Bachelor of Science in Accounting from Butler University - Lacy School of Business in 2001.